Genetically driven CD39 expression shapes human tumor-infiltrating CD8⁺ T-cell functions.

Area of Science:

• Immunology
• Cancer Biology
• Molecular Genetics

Background:

• CD39 is implicated in T-cell exhaustion, a state of functional impairment in immune cells.
• Understanding CD39's role in tumor-infiltrating lymphocytes (TILs) is crucial for cancer immunotherapy.

Purpose of the Study:

• To investigate the functional role of CD39 on CD8+ T cells within various tumor microenvironments.
• To identify genetic factors associated with CD39 expression in CD8+ TILs.
• To explore therapeutic strategies targeting CD39 for restoring T-cell function.

Main Methods:

• Flow cytometry analysis of CD39 expression and associated markers (PD-1, IFN-γ, IL-2, perforin, granzyme B) on CD8+ TILs.
• Ex vivo proliferation assays and in vitro suppression assays.
• Single nucleotide polymorphism (SNP) analysis (rs10748643 A>G).
• Assessment of CD39-inhibiting compounds on T-cell function.

Main Results:

• CD39+ CD8+ TILs exhibited reduced IFN-γ and IL-2 production and increased PD-1 expression, indicative of partial dysfunction.
• Despite reduced effector markers, CD39+ CD8+ TILs showed enhanced ex vivo proliferation inversely correlated with PD-1.
• A novel genetic association was found between SNP rs10748643 A>G and CD39 expression in CD8+ TILs.
• Inhibition of CD39-related ATPases improved CD39+ CD8+ T-cell function ex vivo, and these cells demonstrated suppressive activity in vitro.

Conclusions:

• CD39+ CD8+ TILs represent a partially exhausted T-cell subset associated with early tumor progression.
• SNP rs10748643 A>G may serve as a predictive biomarker for CD39 expression in cancer patients.
• Targeting CD39 offers a promising strategy to reinvigorate exhausted CD8+ T cells in the tumor microenvironment.